CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy (Q44787221)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy |
scientific article published in March 2004 |
Statements
1 reference
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy (English)
1 reference
1 reference
Pier Mannuccio Mannucci
1 reference
Marta Spreafico
1 reference
Simona Maria Siboni
1 reference
Marco Moia
1 reference
1 March 2004
1 reference
1 reference
Identifiers
1 reference